Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
658.30
16.4 (2.55%)
BSENSE

Nov 20

BSE+NSE Vol: 1.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039897,
    "name": "Nephrocare Healt",
    "stock_name": "Nephrocare Healt",
    "full_name": "Nephrocare Health Services Ltd",
    "name_url": "stocks-analysis/nephrocare-healt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "658.30",
    "chg": 16.4,
    "chgp": "2.55%",
    "dir": 1,
    "prev_price": "641.90",
    "mcapval": "6,471.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544647,
    "symbol": "NEPHROPLUS",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE428V01029",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.16 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/nephrocare-healt-10039897-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nephrocare Health Services Ltd Gains 1.03%: 6 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-ltd-gains-103-6-key-factors-driving-the-weeks-mixed-momentum-4269868",
        "imagepath": "",
        "date": "2026-11-21 09:02:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Upgrade to Sell rating on technical improvements</p>\n                    <p><strong>17 Nov:</strong> Mildly bearish momentum amid mixed technical signals</p>\n                    <p><strong>18 Nov:</strong> Strong quarterly gains reported with positive financial trend</p>\n                    <p><strong>19 Nov:</strong> Technical momentum shifts to mildly bearish</p>\n                    <p><strong>20 Nov:</strong> Stock closes at Rs.658.30, up 2.55% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.651.60</div></div>\n             ..."
      },
      {
        "title": "Nephrocare Health Services Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4267618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NephrocareHealt_technicaldot_4267618.png",
        "date": "2026-11-19 08:06:28",
        "description": "Nephrocare Health Services Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. Despite a strong year-to-date return of 38.99%, recent technical indicators suggest caution as the stock’s price momentum shows signs of weakening amid mixed signals from key oscillators and moving averages."
      },
      {
        "title": "Nephrocare Health Services Ltd Reports Strong Quarterly Gains Amid Positive Financial Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-ltd-reports-strong-quarterly-gains-amid-positive-financial-trend-4267321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NephrocareHealt_fintrenddot_4267321.png",
        "date": "2026-11-18 16:00:08",
        "description": "Nephrocare Health Services Ltd has demonstrated a positive shift in its financial trend for the quarter ended September 2026, marked by record-high revenues and profitability metrics despite rising interest expenses. The company’s recent quarterly performance signals a stabilising growth trajectory, although margin pressures remain a concern for investors."
      },
      {
        "title": "Nephrocare Health Services Ltd Faces Mildly Bearish Momentum Amid Mixed Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-ltd-faces-mildly-bearish-momentum-amid-mixed-technical-signals-4264713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NephrocareHealt_technicaldot_4264713.png",
        "date": "2026-11-17 08:03:47",
        "description": "Nephrocare Health Services Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock exhibits a complex interplay of technical indicators that suggest cautious investor sentiment amid mixed signals from key momentum and volume metrics."
      },
      {
        "title": "Nephrocare Health Services Ltd Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-ltd-shows-mixed-technical-signals-amid-price-momentum-shift-4263174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NephrocareHealt_technicaldot_4263174.png",
        "date": "2026-11-16 08:04:55",
        "description": "Nephrocare Health Services Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways consolidation phase. Despite a strong one-week return of 8.44%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Nephrocare Health Services Declines 2.44% Amid Valuation and Technical Shifts",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-declines-244-amid-valuation-and-technical-shifts-4254801",
        "imagepath": "",
        "date": "2026-11-07 09:02:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Valuation reassessment amid price correction</p>\n                    <p><strong>3 Nov:</strong> Positive momentum shift with mixed technical signals</p>\n                    <p><strong>5 Nov:</strong> Strong quarterly gains reported amid margin pressures</p>\n                    <p><strong>5 Nov:</strong> Downgrade to Sell due to quality and valuation concerns</p>\n                    <p><strong>6 Nov:</strong> Technical momentum shifts to mildly bearish</p>\n                    <p><strong>6 Nov:</strong> Week closes at ₹600.90 (-2.44%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\"..."
      },
      {
        "title": "Nephrocare Health Services Ltd Reports Strong Quarterly Gains Amid Margin Pressures",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-ltd-reports-strong-quarterly-gains-amid-margin-pressures-4252379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NephrocareHealt_fintrenddot_4252379.png",
        "date": "2026-11-05 11:01:13",
        "description": "Nephrocare Health Services Ltd has delivered a robust quarterly performance for September 2026, registering record-high revenues and profitability metrics despite rising interest expenses. The company’s financial trend has shifted from very positive to positive, reflecting both operational strength and emerging cost challenges in the healthcare services sector."
      },
      {
        "title": "Nephrocare Health Services Ltd Downgraded to Sell Amid Valuation and Quality Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nephrocare-health-services-ltd-downgraded-to-sell-amid-valuation-and-quality-concerns-4251696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NephrocareHealt_mojoScore_4251696.png",
        "date": "2026-11-05 08:49:44",
        "description": "Nephrocare Health Services Ltd has seen its investment rating downgraded from Hold to Sell as of 4 Nov 2026, reflecting deteriorations in quality metrics and valuation concerns despite some technical improvements. The healthcare services company, classified as a small-cap with a current market price of ₹620.75, faces challenges on multiple fronts including below-average quality grades, very expensive valuation multiples, and mixed financial trends. This comprehensive analysis explores the four key parameters that triggered the rating change and what it means for investors."
      },
      {
        "title": "Nephrocare Health Services Ltd Downgraded to Sell Amid Quality Parameter Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nephrocare-health-services-ltd-downgraded-to-sell-amid-quality-parameter-decline-4251178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NephrocareHealt_qualitydot_4251178.png",
        "date": "2026-11-05 08:00:52",
        "description": "Nephrocare Health Services Ltd has seen its quality grade downgraded from Hold to Sell following a reassessment of its business fundamentals. Despite a robust year-to-date stock return of 32.3%, the company’s underlying financial quality indicators have weakened, raising concerns about its operational consistency and capital efficiency compared to peers in the healthcare services sector."
      }
    ],
    "total": 55,
    "sid": "10039897",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/nephrocare-health-services-10039897"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "20-Nov-2026",
      "details": "Pursuant to Reg 30 of the SEBI Listing Regulations we hereby inform that the Company has scheduled an investor conference call as per the disclosure annexed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI Listing Regulations - Grant Of Esops Under The Nephroplus Employee Stock Option Scheme 2026.",
      "datetime": "17-Nov-2026",
      "details": "We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "17-Nov-2026",
      "details": "Pursuant to Reg 30 of SEBI Listing Regulations 2015 we hereby inform that the Company has approved allotment of 342130 equity shares of Rs. 2/- each pursuant to the exercise of stock options under NephroPlus ESOP Scheme 2011.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

20-Nov-2026 | Source : BSE

Pursuant to Reg 30 of the SEBI Listing Regulations we hereby inform that the Company has scheduled an investor conference call as per the disclosure annexed herewith.

Disclosure Under Regulation 30 Of The SEBI Listing Regulations - Grant Of Esops Under The Nephroplus Employee Stock Option Scheme 2026.

17-Nov-2026 | Source : BSE

We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

17-Nov-2026 | Source : BSE

Pursuant to Reg 30 of SEBI Listing Regulations 2015 we hereby inform that the Company has approved allotment of 342130 equity shares of Rs. 2/- each pursuant to the exercise of stock options under NephroPlus ESOP Scheme 2011.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available